A preclinical study performed by scientists at the University of North Carolina and Duke University has demonstrated the potential for the treatment of ovarian cancer using nanotechnology.

The team used nanoparticle technology to specifically target metastasized ovarian cancer cells and to deliver a chemotherapy drug and a radiotherapy isotope directly to the cancerous cells. In addition to eradicating the cancer, this method was found to lessen the toxicity often associated with traditional treatments. The researchers hope that the targeted nature of these nanopartical therapeutic carriers will aid in the treatment of peritoneal metastasis to the lining of the abdomen, which is a major cause of ovarian cancer deaths.